The preclinical study established the safety and efficacy of haMSCs. Intra-articular injections of haMSCs were safe and improved pain, function and cartilage volume of the knee joint, rendering them a promising novel treatment for knee osteoarthritis. The dosage of 5 × 10⁷ haMSCs exhibited the highest improvement (ClinicalTrials.gov Identifier: NCT01809769).
No takes yet. Share an insight, caveat, or question.
Song et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: